Search

Showing "11155" results for ""

Will the money drain out of AIDS?

Whose fear is it anyway? People with HIV and dentists

Stigma begins at home

Love is a danger

Glaxo to test rival's protease inhibitor, re-engineered to last longer

Starting treatment at lower CD4 cell counts increases risk of HIV drug resistance

Quarter of HIV-positive women in US not having annual checks for cervical cancer

Detectable viral load means risk of superinfection for long-term HIV-positive couples

Hepatitis B may increase all-cause mortality in HIV-positive people, according to meta-analysis

Meeting the non-medical needs of people with HIV in England: document sets ambitious goals

Nelfinavir treatment has no effect on risk of cancers

Over 3000 children diagnosed with HIV in Lusaka after hospital introduces opt-out HIV testing

Pooled procurement may not deliver lower ARV prices

High viral load and low CD4 cell count risk factors for non-HIV-related illnesses

`Shock and kill` approach awakens latent HIV in test tube

Should we spare the nukes? NRTI HIV drugs may impair success of hepatitis C treatment

Hepatitis B hasn’t gone away – and may come back

New drug for MDR-TB does well in trial

Receive the latest HIV research and conference news

Showing "11155" results for ""

Will the money drain out of AIDS?

Whose fear is it anyway? People with HIV and dentists

Stigma begins at home

Love is a danger

Glaxo to test rival's protease inhibitor, re-engineered to last longer

Starting treatment at lower CD4 cell counts increases risk of HIV drug resistance

Quarter of HIV-positive women in US not having annual checks for cervical cancer

Detectable viral load means risk of superinfection for long-term HIV-positive couples

Hepatitis B may increase all-cause mortality in HIV-positive people, according to meta-analysis

Meeting the non-medical needs of people with HIV in England: document sets ambitious goals

Nelfinavir treatment has no effect on risk of cancers

Over 3000 children diagnosed with HIV in Lusaka after hospital introduces opt-out HIV testing

Pooled procurement may not deliver lower ARV prices

High viral load and low CD4 cell count risk factors for non-HIV-related illnesses

`Shock and kill` approach awakens latent HIV in test tube

Should we spare the nukes? NRTI HIV drugs may impair success of hepatitis C treatment

Hepatitis B hasn’t gone away – and may come back

New drug for MDR-TB does well in trial

Receive the latest HIV research and conference news